You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. PLURI INC

Pluri Inc XNAS: PLUR

Pluri Inc Live Share Price Today, Share Analysis and Chart

Download real time

3.94 0.31 (8.54%)

New 52W Low in past week

22,192 XNAS Volume

High volume+gain today

XNAS 08 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Pluri Inc Key Metrics

Select

Market Capitalization

Below industry Median
27.6

PE TTM

Negative PE TTM
-1.4

PEG TTM

Negative PEG TTM
-0.1

Price to Book

Negative Price to Book
-3.4

Institutional holding current Qtr %

Low in industry
1.1

Revenue Growth Qtr YoY %

Below industry Median
76.2

Operating Revenue growth TTM %

Below industry Median
89.9

Net Profit Qtr Growth YoY %

Below industry Median
39.7

Net Profit TTM Growth %

Below industry Median
17.1

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-2,679.5

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-3,204

Piotroski Score

Below industry Median
2

Rel Perf vs Sector quarter%

-8.2

ROE Annual %

Negative ROE Annual %
-310.6

RoA Annual %

Negative RoA Annual %
-46.3
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
2.7 / 100
Momentum Score
Technically Bearish
24.3 / 100
Analyst Price Target
No estimates available

15

S

14

W

0

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Pluri Inc Live Price Chart

Switch to TradingView
Fetching data ...

Pluri Inc Stock Analysis

Pluri Inc stock analysis with key metrics, changes, and trends.

Pluri Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$0.33 M13.59%positive

Annual Revenue rose 13.59%, in the last year to $0.33 M. Its sector's average revenue growth for the last fiscal year was 7.48%.

Annual Net Profit$20.89 M26.25%positive

Annual Net Profit rose 26.25% in the last year to $20.89 M. Its sector's average net profit growth for the last fiscal year was -32.62%.

Price to Earning Ratio-1.39-negative

Price to Earning Ratio is -1.39, which is negative.

Stock Price$3.94-28.23%negative

Stock Price fell 28.23% and underperformed its sector by 24.48% in the past year.

Quarterly Revenue$0.18 M76.19%positive

Quarterly Revenue rose 76.19% YoY to $0.18 M. Its sector's average revenue growth YoY for the quarter was 5.95%.

Quarterly Net profit$2.96 M39.73%positive

Quarterly Net profit rose 39.73% YoY to $2.96 M. Its sector's average net profit growth YoY for the quarter was -47.55%.

Debt to Equity Ratio308.46-negative

Debt to Equity Ratio of 308.46 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-310.58 %-310.58%negative

Return on Equity(ROE) for the last financial year was -310.58%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.26 %0%negative

Mutual Fund Holding decreased by 0% in the last quarter to 0.26.

Promoter Share Holding19.75 %-7.41%negative

Promoter Share Holding decreased by 7.41% in the most recent quarter to 19.75%.

Interest Coverage Ratio-23.65-negative

Interest Coverage Ratio is -23.65, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding1.10 %0%neutral

Institutional Holding remained the same in the last quarter at 1.1%.

VIEW LESS


Loading data..

Pluri Inc - Company Profile

What does Pluri Inc do?

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Pluri Inc Management structure

All Gross Remunerations are in USD
Ms. Chen Franco-Yehuda
Director, Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
-
2025
Gross Remuneration
Year
Ms. Liat Zalts
Director of Finance
-
2025
Gross Remuneration
Year

Pluri Inc Board of directors

All Gross Remunerations are in USD
Ms. Chen Franco-Yehuda
Director, Chief Financial Officer, Principal Accou
-
2025
Gross Remuneration
Year
Mr. Alejandro Weinstein
Director
-
2025
Gross Remuneration
Year

Pluri Inc FAQ

How is Pluri Inc today?
Pluri Inc today is trading in the green, and is up by 8.54% at 3.94.
Pluri Inc is currently trading up 8.54% on an intraday basis. In the past week the stock fell -8.37%. stock has been down -15.09% in the past quarter and fell -28.23% in the past year. You can view this in the overview section.